NDC 71335-9701-04 - Hydromorphone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-9701
- Requested NDC
- 71335-9701-04
- Package NDCs from labels
- 71335-9701-1, 71335-9701-2, 71335-9701-3, 71335-9701-4, 71335-9701-5, 71335-9701-6, 71335-9701-7, 71335-9701-8, 71335-9701-9, 71335-9701-0, 71335-9701-04
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydromorphone Hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-9701-0 | Hydromorphone Hydrochloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 104 | |
| 71335-9701-1 | Hydromorphone Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 104 | |
| 71335-9701-2 | Hydromorphone Hydrochloride | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 104 | |
| 71335-9701-3 | Hydromorphone Hydrochloride | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | 104 | |
| 71335-9701-4 | Hydromorphone Hydrochloride | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 104 | |
| 71335-9701-5 | Hydromorphone Hydrochloride | 25 in 1 BOTTLE, PLASTIC | TABLET | 25 | 104 | |
| 71335-9701-6 | Hydromorphone Hydrochloride | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 104 | |
| 71335-9701-7 | Hydromorphone Hydrochloride | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 104 | |
| 71335-9701-8 | Hydromorphone Hydrochloride | 56 in 1 BOTTLE, PLASTIC | TABLET | 56 | 104 | |
| 71335-9701-9 | Hydromorphone Hydrochloride | 140 in 1 BOTTLE, PLASTIC | TABLET | 140 | 104 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-9701 | HYDROMORPHONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, 10 package rows | 20250303_c48e2e9a-cb5b-46b8-b6be-3dd76e80d0ca.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-9701-0 | EA - Each | 71335-9701 | 20b95f91-80dc-4662-88e7-a6f283b88da7 | 1 | 2025-05-14 |
| 71335-9701-1 | EA - Each | 71335-9701 | 64219e21-7222-44d7-b597-ea0ab5aa25aa | 1 | 2025-05-14 |
| 71335-9701-7 | EA - Each | 71335-9701 | ad4af359-9c1a-4093-8437-635941cd2fdf | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Redpharm Drug | 59d88866-e1ba-9d97-e063-6394a90a7b27 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 897696 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 67e79859-4efc-4ea7-8211-cadf746bc864 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 31d5a37a-0e90-4e88-be14-75c877be9de2 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Dilaudid | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 9eebd88a-5632-460f-b7b6-26c8a180540d | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e034eb96-03e0-46e1-8b92-5e1f94555e7b | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | SpecGx LLC | 4c5c1cc8-c42b-46e3-ad68-8e22f57101f2 | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | 897696 897710 897702 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | 2427814c-f32b-8ac5-99b8-5e886fd2d001 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | NDA019892 897696 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 53ddcacc-99e4-8b21-e063-6394a90a3e79 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | NDA019892 897702 L960UP2KRW |
| Dilaudid | HYDROMORPHONE HYDROCHLORIDE | Rhodes Pharmaceuticals LLC | d6b40e39-a57e-402c-b4f6-7041e832f837 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | NDA019892 897696 897657 897710 897702 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Teva Parenteral Medicines, Inc. | f0b78db9-a38c-41bb-8233-5e93f7f18c5c | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Rhodes Pharmaceuticals LLC | 37565441-0d95-4743-a695-d7b3326f58a1 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | NDA019892 42858-302 897696 897657 897710 897702 b786b01b-46f9-4a00-a667-699e813a741b 37565441-0d95-4743-a695-d7b3326f58a1 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | American Health Packaging | fab97112-e276-40e0-bc82-0a29d7fa75fa | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | 897657 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | 3832ede8-d3fc-455d-ecab-3b77be5869f5 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | c48e2e9a-cb5b-46b8-b6be-3dd76e80d0ca | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | NDA019892 71335-9701-9 71335-9701-4 71335-9701-6 71335-9701-2 71335-9701-3 71335-9701-1 71335-9701-7 71335-9701-0 71335-9701-5 71335-9701-8 71335-9701 71335970104 897702 b9b96266-fe94-4282-915f-277433e1ca26 c48e2e9a-cb5b-46b8-b6be-3dd76e80d0ca L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 2026-03-02 | Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | American Health Packaging | e4758743-9b2c-4612-8399-ad2db372e2b7 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 897696 897702 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | cc574063-6ede-4da7-82c4-7450c92b229b | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 897657 897710 897702 L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | f9ca2ef5-46d8-475a-a26e-f7c8becd6db7 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | c729424e-e483-4bf8-b86c-ce56636dcffa | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | e9c9ef18-7dfc-4322-b2fc-29b934c30f8b | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | L960UP2KRW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.